Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWJ1248 for Prevention of COVID-19 After Exposure
NCT04721535Phase 3Terminated
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jun 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Daewoong Pharmaceutical. Started Jun 2021; status: terminated.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04721535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721535.